Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis.
J Investig Allergol Clin Immunol
; 21(5): 333-47; quiz follow 347, 2011.
Article
em En
| MEDLINE
| ID: mdl-21905496
ABSTRACT
BACKGROUND:
There are no Spanish guidelines or consensus statement on bradykinin-induced angioedema.AIM:
To review the pathophysiology, genetics, and clinical symptoms of the different types of bradykinin-induced angioedema and to draft a consensus statement in light of currently available scientific evidence and the experience of experts. This statement will serve as a guideline to health professionals.METHODS:
The consensus was led by the Spanish Study Group on Bradykinin-Induced Angioedema (SGBA), a working group of the Spanish Society of Allergology and Clinical Immunology. A review was conducted of scientific papers on different types of bradykinin-induced angioedema (hereditary and acquired angioedema due to C1 inhibitor deficiency, hereditary angioedema related to estrogens, angioedema induced by angiotensin-converting enzyme inhibitors). Several discussion meetings of the SGBA were held in Madrid to reach the consensus.RESULTS:
The pathophysiology, genetics, and clinical symptoms of the different types of angioedema are reviewed. Diagnostic approaches are discussed and the consensus reached is described.CONCLUSIONS:
A review of bradykinin-induced angioedema and a consensus on diagnosis are presented.
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Vasodilatadores
/
Bradicinina
/
Vasoespasmo Coronário
/
Hipersensibilidade a Drogas
/
Angioedema
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Qualitative_research
/
Risk_factors_studies
/
Screening_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
J Investig Allergol Clin Immunol
Assunto da revista:
ALERGIA E IMUNOLOGIA
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Espanha